Top 10 Stock Picks for November 2025: Best Stocks to Buy Now for Growth Amid AI Boom, Tariff Concerns, and Fed Rate Cuts
Introduction
The stock market in November 2025 continues to navigate a complex landscape shaped by President Trump's tariff policies, which have dialed back slightly but still contribute to persistent inflation around 3.5% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.75% so far this year—have fueled a market melt-up, with the S&P 500 rallying 36% over the past six months on strong corporate earnings and AI optimism. Gold prices have surged past $4,000 an ounce as a hedge, while cryptocurrencies hit new highs. However, warnings of an AI bubble abound, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy. Drawing from analyses by Zacks, Forbes, ValueSense, US News, and Morningstar, this list highlights 10 high-conviction picks emphasizing AI-driven growth, resilient sectors, and undervalued opportunities for diversification in a bifurcated economy.
1. Western Digital (WDC)
- Recent Performance: YTD +232%
- Annual performance since listed: 8.3%/yr since 1978 (TotalRealReturns)
- Data Storage (Growth): Storage for AI boom; undervalued with earnings rebound.
- The recent price surge is driven by strong demand for data storage in AI and cloud sectors, with analysts maintaining a Buy consensus and potential for further upside.
- Recent Market Capitalisation: $45 B
- Valuation Assessment: Undervalued. Hedge funds flag as top NASDAQ bargain; DCF ~$108 (16% under at $129), forward P/E 26x (below peers 33x fair), with 2025 EPS +13% upside.
- Final Recommendation: Buy (Medium confidence, 12 months)
2. Nvidia (NVDA)
- Recent YTD Performance: ~+49%. (TradingView)
- Recent Market Capitalisation: ~$4.9 Trillion
- Annual performance since listed: 34.5%/yr since 1999 (TotalRealReturns)
- Stock price: ~$202 (TradingView)
- Valuation: Overvalued (P/E 57x vs. fair 35x; 65% premium to intrinsic) (blog.valuesense.io)
- PE ratio: 52
- Gross margin: 75.9%
- TTM EPS: $2.54
- EPS growth outlook for next year: 48.9%
- Debt/Equity ratio: 0.16
- Recommendation: Buy (Gemini 2.5 Pro, Grok 4)
- Confidence Level: Medium (Grok 4)
- Expected Timeframe: 12 months (Gemini 2.5 Pro)
- Expected Timeframe: Buy and hold for 12 months, given recent volatility from competition concerns but strong long-term AI demand outlook. (Grok 4)
- 1-Month Price Target: $220
3. Robinhood Markets, Inc. (HOOD)
- Recent YTD Performance: +285% year-to-date with a 561% gain over 1 year; recent surge driven by S&P 500 inclusion and strong revenue growth. (TradingView)
- Recent Market Capitalisation: $132 B
- Annual performance since listed: 34%/yr since 2021 (TotalRealReturns)
- Valuation Assessment: Overvalued. Trading at 26x P/S (vs. 5-year avg 8.6x), DCF models peg it 69–80% above intrinsic value ($42–$64 fair), with forward P/E implying excessive growth pricing.
- Final Recommendation: Hold
- Confidence Level: Medium
- Expected Timeframe: 3-6 months
4. Seagate Technology (STX)
- Recent Performance: YTD +189%, 1M +8.7%.
- Data Storage (Growth): AI-driven storage and AI data center demand; top YTD performer with strong forecasts.
- Recent Market Capitalisation: $53 B
- Annual performance since listed: 15.6%/yr since 2002 (TotalRealReturns)
- Valuation Assessment: Fairly valued with upside. P/E ~21x (near industry 21x), DCF estimates $148–$163 fair (vs. ~$211 current), but analysts' Buy consensus and 2025 revenue +39% suggest undervalued growth.
- Final Recommendation: Buy
- Confidence Level: High
- Expected Timeframe: 12-24 months
- 1 month price target: $235
5. Micron Technology (MU)
- Recent Performance: YTD +123%, 1M +10%.
- Annual performance since listed: 10%/yr since 1984 (TotalRealReturns)
- Semiconductors (Growth): Memory chips for AI data centers; Zacks #1 Rank, 50%+ EPS growth expected.
- Valuation Assessment: Undervalued. Base DCF $201 (10% under at $182), forward P/E attractive vs. growth; analysts see 30% upside despite cyclical risks.
- Final Recommendation: Buy
- Confidence Level: High
- Expected Timeframe: 12-24 months
- 1 month price target: $210
6. Palantir Technologies (PLTR)
- YTD - October 2025 range: +120 - 135% (TradingView)
- Recent Market Capitalisation: $410 B
- Annual performance since listed: 74%/yr since 2020 (TotalRealReturns)
- Valuation Assessment: Significantly overvalued. DCF intrinsic ~$19 (89% over at $179), P/S multiples dwarf peers; scores 0/6 on value checks, with recession risks amplifying premium.
- Final Recommendation: Hold
- Confidence Level: Medium
- Expected Timeframe: 3 months
Palantir trades at significantly higher multiples, suggesting it is more overvalued relative to current and forward earnings/sales, even accounting for its growth narrative.
7. GE Vernova (GEV)
- Recent Performance: YTD +79%, 1M +10.5%. (TradingView)
- Energy tech spin-off with renewable focus; 86.4% YTD driven by green energy transition.
- Recent Market Capitalisation: ~$162 B. (TradingView)
- Annual performance since listed: 147%/yr since 2024 (TotalRealReturns)
- Valuation Assessment: Overvalued. Trades at 57x forward P/E (above 47x historical avg), analyst targets imply downside; DCF suggests premium amid supply risks.
- Final Recommendation: Hold
- Confidence Level: Medium
- Expected Timeframe: 3-6 months
8. CVS Health (CVS)
- Recent YTD Performance: ~+80%. (TradingView)
- Recent Market Capitalisation: ~103 B. (TradingView)
- Annual performance since listed: 5.9%/yr since 1973 (TotalRealReturns)
- Valuation Assessment: Deeply undervalued. DCF intrinsic $151 (49% under at $77), P/S 0.2x far below peers; 2025 EPS +13% and restructuring signal rebound potential.
- CVS Health (CVS) has delivered significant long-term shareholder returns, with a total real return of +5.92% per year (inflation-adjusted) from February 1973 to October 2025, and an exponential trendline return of +8.20%/year, indicating strong growth over decades. However, performance varies year-to-year, with recent years (2022-2024) showing negative returns, contrasting with substantial positive years in the past and a strong year-to-date performance in 2025. (Total Real Returns)
- Final Recommendation: Hold (Medium confidence, 12 months)
9. General Electric (GE)
- Recent YTD Performance: ~+78%. (TradingView)
- Recent Market Capitalisation: ~316 B. (TradingView)
- Annual performance since listed: 5.9%/yr since 1962 (TotalRealReturns)
- Valuation Assessment: Overvalued. DCF $188 (33% over at $282), P/E 42x exceeds fair 35x; 2025 rally (78% YTD) prices in defense growth, but tariffs loom.
- Recommendation: Hold (Medium confidence, 12 months)
- 1 month price target: $300
10. Newmont Corp. (NEM)
- Recent Performance: YTD ~+112%
- Annual performance since listed: 2.86%/yr since 1980 (TotalRealReturns)
- Mining (Safety/Hedge): Gold leader benefiting from record prices and safe-haven demand; Zacks #1 Rank with 67% EPS growth forecast.
- Recent Market Capitalisation: $95 B
- Valuation Assessment: Fairly valued to slightly undervalued. Forward P/E ~17x (below peer average 23x), with Zacks noting undervaluation potential; DCF shows mild 5% overvaluation, but value grade B signals opportunity.
- However, performance varies year-to-year, with recent years (2022-2024) showing negative returns, contrasting with a strong year-to-date performance in 2025.
- Recommendation: Hold (Medium confidence, 12-24 months)
Ranking Methodology
- YTD Performance: Prioritized high returns
Annual Performance since listed.
- Market Capitalization: Favored large caps for liquidity and stability (e.g., NVDA $4.93T).
- Data Source: TradingView, ValueSense, and Yahoo Finance.
- Drivers: AI enthusiasm propelling tech stocks, with Nvidia and Broadcom leading amid $120B AI revenue targets by 2030. Fed cuts support growth, but tariffs risk slowing it.
- Trends: Bubble fears in AI, with valuations stretched; international markets lag due to dollar strength and tariff uncertainty. Crypto and gold surges reflect inflation hedges.
Disclaimer
This is not financial advice. Past performance doesn’t guarantee future results. Consult a financial advisor and conduct your own research before investing.While efforts have been made to ensure the accuracy and timeliness of the information, One Day Advisor and the article’s authors do not guarantee the completeness, reliability, or suitability of the content for any particular purpose. Readers are encouraged to verify details independently and consult qualified professionals before making any business, investment, or healthcare decisions based on the information provided.
The article may reference ongoing developments, regulatory actions, or market events that are subject to change. One Day Advisor is not responsible for any losses or damages arising from the use of this information.
References:

Comments